An Open Label, Randomized, Prospective, Multicentric Clinical Trial to Evaluate the Efficacy and Safety of Parenteral Placentrex with OralAzithromycin vs OralAzithromycin alone in Chronic and Recurrent Pelvic Inflammatory Disease.

Albert David Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年8月21日

研究概览

暂无简介。

•1. Female subjects in the age group of 18 to 45 years with lower abdominal or pelvic pain and cervical motion or pelvic tenderness, adnexal tenderness based on historical USG.
•2. Patients diagnosed to have Recurrent PID.
•3. Patients with primary or secondary infertility with diagnosis of PID.
•4. Patients with persistent PID despite antibiotic treatment within past 6 weeks.
•5. Willing to receive intramuscular (IM) injections for 14 days

•1. Postmenopausal women
•2. Subjects who were pregnant or breastfeeding.
•3. Subjects on active treatment or with evidence of active tuberculosis/STD.
•4. Subjects with known case of endometriosis
•5. Any hepatic or renal impairment
•6. Participation in any other clinical trial in the past one month.
•7. Patients unlikely to comply with trial protocol.
•8. Any other debilitating systemic condition in the opinion of the Investigator that would deem the subject unfit to participate in the trial.

发起方

Albert David Limited